Newsfeeds - Spark Newswire

1 minute read

General

Stevanato Group And Gerresheimer To Collaborate On Vial Platform

Today, 9:37 AM

DÜSSELDORF, Germany and PIOMBINO DESE, Italy, Sept. 7, 2022 /CNW/ -- Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech

STVN

34 minute read

Earnings

Earnings Scheduled For August 4, 2022

By Benzinga Insights

Today, 9:37 AM

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

AAOI

20 minute read

Earnings Scheduled For May 10, 2022

By Benzinga Insights

Today, 9:37 AM

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

ABCL

1 minute read

Morgan Stanley Maintains Overweight on Stevanato Group, Lowers Price Target to $22

By Benzinga Newsdesk

Today, 9:37 AM

Morgan Stanley maintains Stevanato Group (NYSE:STVN) with a Overweight and lowers the price target from $30 to $22.

STVN

1 minute read

B of A Securities Maintains Buy on Stevanato Group, Lowers Price Target to $24

By Benzinga Newsdesk

Today, 9:37 AM

B of A Securities analyst Derik De Bruin maintains Stevanato Group (NYSE:STVN) with a Buy and lowers the price target from $30 to $24.

STVN

1 minute read

Wells Fargo Maintains Overweight on Stevanato Group, Lowers Price Target to $21

By Benzinga Newsdesk

Today, 9:37 AM

Wells Fargo analyst Timothy Daley maintains Stevanato Group (NYSE:STVN) with a Overweight and lowers the price target from $26 to $21.

STVN

1 minute read

Citigroup Maintains Buy on Stevanato Group, Lowers Price Target to $23

By Benzinga Newsdesk

Today, 9:37 AM

Citigroup analyst Patrick Donnelly maintains Stevanato Group (NYSE:STVN) with a Buy and lowers the price target from $27 to $23.

STVN

6 minute read

Earnings Scheduled For March 8, 2022

By Benzinga Insights

Today, 9:37 AM

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.

ABM

2 minute read

Stevanato Group Extends Pen Injector Technology Licensing Agreement With Haselmeier; Terms Not Disclosed

By Benzinga Newsdesk

Today, 9:37 AM

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension to its licensing agreement with

STVN

32 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 9:37 AM

On Thursday, 615 stocks hit new 52-week lows.

AAOI